SCHEMBL6416360

SCHEMBL6416360

O=C1SC(CN2CCC(Cc3cc(Cl)ccc3Cl)CC2)CN1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.40
HTR1A P08908 1/20 0.40
CCR3 P51677 1/20 0.40
SLC6A2 P23975 4/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 3/20 0.38
ATM Q13315 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TMEM97 Q5BJF2 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6416434 0.94 MEN1 (0.41) SLC6A4HTR1ACCR3SLC6A2MEN1
SCHEMBL6412761 0.90 SLC6A4 (0.40) SLC6A4HTR1ASLC6A2ALDH1A1ATM
SCHEMBL6417606 0.90 P2RX7 (0.41) SLC6A4HTR1ACCR3SLC6A2MEN1
SCHEMBL6412140 0.88 HTR1A (0.46) SLC6A4HTR1ACCR3MEN1POLB
SCHEMBL6414071 0.88 HTR1A (0.57) SLC6A4HTR1AMEN1POLBKMT2A
SCHEMBL6415056 0.86 GRIN1 (0.35) SLC6A4HTR1ACCR3MEN1POLB
SCHEMBL6416461 0.86 HTR1A (0.46) SLC6A4HTR1ACCR3POLBALDH1A1
SCHEMBL6417947 0.85 HTR1A (0.46) SLC6A4HTR1ACCR3MEN1POLB
SCHEMBL6411979 0.85 ALDH1A1 (0.45) SLC6A4HTR1ACCR3SLC6A2MEN1
SCHEMBL6417425 0.84 HTR1A (0.43) SLC6A4HTR1AHTTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065140-A1 Serotonine reuptake inhibitor SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2005-03-24 US disclosed
EP-1466901-A1 SEROTONINE REUPTAKE INHIBITOR SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065140-A1 Serotonine reuptake inhibitor HTR1A, SLC6A4, SLC6A2 SLC6A4 2/4885HTR1A 1/4885CCR3 4569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.